Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cost Of Revenue | 1,540 | 4,546 | 7,307 | 8,642 | -- |
| Gross Profit | -1,540 | -4,546 | -7,307 | -8,642 | -- |
| Selling General And Administration | 562,361 | 462,107 | 165,506 | 258,144 | -- |
| General And Administrative Expense | 341,425 | 406,865 | 154,355 | 233,381 | -- |
| Research And Development | 19,775 | 54,564 | 124,473 | 65,552 | -- |
| Other Operating Expenses | 2.0M | 1.0M | 303,752 | 423,266 | -- |
| Operating Expense | 2.6M | 1.5M | 593,731 | 746,962 | -- |
| Operating Income | -2.6M | -1.5M | -601,038 | -755,604 | -- |
| EBIT | -2.6M | -1.5M | -601,038 | -755,604 | -- |
| Interest Income | 18,879 | 7,761 | 6,437 | 371.00 | -- |
| Interest Income Non Operating | 18,879 | 7,761 | 6,437 | 371.00 | -- |
| Net Interest Income | 18,879 | 7,761 | 6,437 | 371.00 | -- |
| Other Income Expense | 1.3M | -2.4M | -393,927 | 20,551 | -- |
| Other Non Operating Income Expenses | -- | -- | -- | 28,988 | -- |
| Special Income Charges | 1.4M | -2.4M | -472,189 | 0.00 | -- |
| Gain On Sale Of Security | -19,174 | -37,801 | 78,262 | -8,437 | -- |
| Pretax Income | -1.2M | -3.9M | -988,528 | -734,682 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -1.2M | -3.9M | -988,528 | -734,682 | -- |
| Net Income From Continuing Operation Net Minority Interest | -1.2M | -3.9M | -988,528 | -734,682 | -- |
| Net Income Including Noncontrolling Interests | -1.2M | -3.9M | -988,528 | -734,682 | -- |
| Net Income Common Stockholders | -1.2M | -3.9M | -988,528 | -734,682 | -- |
| Net Income | -1.2M | -3.9M | -988,528 | -734,682 | -- |
| EBITDA | -2.6M | -1.5M | -593,731 | -746,962 | -- |
| Normalized EBITDA | -3.9M | 857,601 | -199,804 | -738,525 | -- |
| Reconciled Depreciation | 1,540 | 4,546 | 7,307 | 8,642 | -- |
| Basic EPS | -0.02 | -0.13 | -0.04 | -0.05 | -- |
| Diluted EPS | -0.02 | -0.13 | -0.04 | -0.05 | -- |
| Basic Average Shares | 52.3M | 31.0M | 22.0M | 13.9M | -- |
| Diluted Average Shares | 52.3M | 31.0M | 22.0M | 13.9M | -- |
| Total Unusual Items | 1.3M | -2.4M | -393,927 | -8,437 | -- |
| Total Unusual Items Excluding Goodwill | 1.3M | -2.4M | -393,927 | -8,437 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -2.6M | -1.5M | -594,601 | -726,245 | -- |
| Diluted NI Availto Com Stockholders | -1.2M | -3.9M | -988,528 | -734,682 | -- |
| Gain On Sale Of Business | 0.00 | 58,164 | 0.00 | -- | -- |
| Gain On Sale Of Ppe | 1.4M | -682,752 | -244,065 | 0.00 | -- |
| Impairment Of Capital Assets | 0.00 | 1.7M | 228,124 | 0.00 | -- |
| Net Income Continuous Operations | -1.2M | -3.9M | -988,528 | -734,682 | -- |
| Net Non Operating Interest Income Expense | 18,879 | 7,761 | 6,437 | 371.00 | -- |
| Other Gand A | 177,719 | 278,018 | 130,812 | 99,946 | -- |
| Reconciled Cost Of Revenue | 1,540 | 4,546 | 7,307 | 8,642 | -- |
| Salaries And Wages | 163,706 | 128,847 | 23,543 | 133,435 | -- |
| Selling And Marketing Expense | 220,936 | 55,242 | 11,151 | 24,763 | -- |
| Total Expenses | 2.6M | 1.5M | 601,038 | 755,604 | -- |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 1.1M | 298,594 | 523,948 | 141,819 | -- |
| Cash Cash Equivalents And Short Term Investments | 1.1M | 330,594 | 613,948 | 141,819 | -- |
| Other Short Term Investments | 0.00 | 32,000 | 90,000 | 0.00 | -- |
| Accounts Receivable | 122,906 | 254,161 | 50,992 | 49,832 | -- |
| Receivables | 122,906 | 254,161 | 50,992 | 49,832 | -- |
| Prepaid Assets | 48,566 | 80,532 | 8,532 | 13,213 | -- |
| Current Assets | 1.2M | 665,287 | 673,472 | 204,864 | -- |
| Net PPE | 633,275 | 222,671 | 2.5M | 2.4M | -- |
| Other Non Current Assets | 30,107 | 12,782 | 72,139 | 72,770 | -- |
| Total Non Current Assets | 663,382 | 303,203 | 2.6M | 2.5M | -- |
| Total Assets | 1.9M | 968,490 | 3.3M | 2.7M | -- |
| Accounts Payable | 101,109 | 125,873 | 68,110 | 86,566 | -- |
| Payables | 404,533 | 749,616 | 438,831 | 356,403 | -- |
| Payables And Accrued Expenses | 404,533 | 749,616 | 438,831 | 356,403 | -- |
| Current Liabilities | 404,533 | 749,616 | 438,831 | 356,403 | -- |
| Other Non Current Liabilities | 31,309 | 13,816 | -- | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 31,309 | 13,816 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 435,842 | 763,432 | 438,831 | 356,403 | -- |
| Common Stock | 21.2M | 19.0M | 17.8M | 16.5M | -- |
| Capital Stock | 21.2M | 19.0M | 17.8M | 16.5M | -- |
| Retained Earnings | -22.2M | -21.0M | -17.1M | -16.1M | -- |
| Gains Losses Not Affecting Retained Earnings | 240,655 | 178,682 | 179,170 | -17,448 | -- |
| Other Equity Adjustments | 240,655 | 178,682 | 179,170 | -17,448 | -- |
| Common Stock Equity | 1.5M | 205,058 | 2.9M | 2.3M | -- |
| Stockholders Equity | 1.5M | 205,058 | 2.9M | 2.3M | -- |
| Total Equity Gross Minority Interest | 1.5M | 205,058 | 2.9M | 2.3M | -- |
| Total Capitalization | 1.5M | 205,058 | 2.9M | 2.3M | -- |
| Net Tangible Assets | 1.5M | 205,058 | 2.9M | 2.3M | -- |
| Tangible Book Value | 1.5M | 205,058 | 2.9M | 2.3M | -- |
| Working Capital | 841,677 | -84,329 | 234,641 | -151,539 | -- |
| Invested Capital | 1.5M | 205,058 | 2.9M | 2.3M | -- |
| Share Issued | 61.1M | 37.9M | 25.9M | 14.6M | -- |
| Ordinary Shares Number | 61.1M | 37.9M | 25.9M | 14.6M | -- |
| Dueto Related Parties Current | 303,424 | 623,743 | 370,721 | 269,837 | -- |
| Long Term Provisions | -- | 13,816 | -- | -- | -- |
| Non Current Accounts Receivable | -- | 67,750 | -- | -- | -- |
| Other Equity Interest | 2.3M | 2.1M | 2.0M | 1.9M | -- |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -907,969 | -1.1M | -497,929 | -396,825 | -- |
| Cash Flow From Continuing Operating Activities | -907,969 | -1.1M | -497,929 | -396,825 | -- |
| Depreciation And Amortization | 1,540 | 4,546 | 7,307 | 8,642 | -- |
| Depreciation Amortization Depletion | 1,540 | 4,546 | 7,307 | 8,642 | -- |
| Stock Based Compensation | 163,706 | 128,847 | 23,543 | 133,435 | -- |
| Change In Working Capital | 101,880 | 340,727 | 85,949 | 210,926 | -- |
| Changes In Account Receivables | 211,979 | 81.00 | -1,160 | 1,114 | -- |
| Change In Receivables | 211,979 | 81.00 | -1,160 | 1,114 | -- |
| Change In Payables And Accrued Expense | -142,065 | 412,646 | 82,428 | 202,964 | -- |
| Change In Payable | -142,065 | 412,646 | 82,428 | 202,964 | -- |
| Other Non Cash Items | 44,380 | -- | -- | -28,988 | -- |
| Capital Expenditure | -319,123 | -547,005 | -385,113 | -360,219 | -- |
| Purchase Of PPE | -319,123 | -547,005 | -385,113 | -360,219 | -- |
| Net PPE Purchase And Sale | -319,123 | -547,005 | -358,743 | -358,819 | -- |
| Sale Of Business | 0.00 | 242,280 | 0.00 | -- | -- |
| Sale Of Investment | 30,405 | 23,500 | 0.00 | 33,338 | -- |
| Net Investment Purchase And Sale | 30,405 | 23,500 | 0.00 | 33,338 | -- |
| Investing Cash Flow | -304,681 | -284,903 | -352,240 | -283,309 | -- |
| Cash Flow From Continuing Investing Activities | -304,681 | -284,903 | -352,240 | -283,309 | -- |
| Issuance Of Capital Stock | 2.0M | 1.1M | 1.2M | 608,701 | -- |
| Net Common Stock Issuance | 2.0M | 1.1M | 1.2M | 608,701 | -- |
| Financing Cash Flow | 2.0M | 1.1M | 1.2M | 608,701 | -- |
| Cash Flow From Continuing Financing Activities | 2.0M | 1.1M | 1.2M | 608,701 | -- |
| Effect Of Exchange Rate Changes | 28,788 | 242.00 | 49,006 | -618.00 | -- |
| Changes In Cash | 747,356 | -225,596 | 333,123 | -71,433 | -- |
| Beginning Cash Position | 298,594 | 523,948 | 141,819 | 213,870 | -- |
| End Cash Position | 1.1M | 298,594 | 523,948 | 141,819 | -- |
| Free Cash Flow | -1.2M | -1.6M | -883,042 | -757,044 | -- |
| Asset Impairment Charge | 0.00 | 1.7M | 228,124 | 0.00 | -- |
| Change In Account Payable | -24,764 | 69,812 | -18,456 | -43,284 | -- |
| Change In Prepaid Assets | 31,966 | -72,000 | 4,681 | 6,848 | -- |
| Common Stock Issuance | 2.0M | 1.1M | 1.2M | 608,701 | -- |
| Depreciation | 1,540 | 4,546 | 7,307 | 8,642 | -- |
| Gain Loss On Investment Securities | 1,595 | 6,500 | -- | 9,162 | -- |
| Gain Loss On Sale Of Business | 0.00 | 624,588 | 0.00 | -- | -- |
| Gain Loss On Sale Of PPE | -- | 0.00 | 244,065 | 0.00 | 819,036 |
| Net Business Purchase And Sale | 0.00 | 242,280 | 0.00 | -- | -- |
| Net Foreign Currency Exchange Gain Loss | -6,646 | 139.00 | -56,389 | 4,680 | -- |
| Net Income From Continuing Operations | -1.2M | -3.9M | -988,528 | -734,682 | -- |
| Net Other Investing Changes | -15,963 | -3,678 | 6,503 | 42,172 | -- |
| Operating Gains Losses | -5,051 | 631,227 | 187,676 | 13,842 | -- |
| Proceeds From Stock Option Exercised | -- | -- | -- | 0.00 | 17,683 |
| Provisionand Write Offof Assets | 16,058 | 0.00 | -- | -- | -- |
| Sale Of PPE | -- | 0.00 | 26,370 | 1,400 | 37,038 |
| Unrealized Gain Loss On Investment Securities | 0.00 | 28,000 | -42,000 | 0.00 | -- |